Min-Jun Baek
Korea Advanced Institute of Science and Technology · 薬学
研究室紹介
Professor Min-Jun Baek's research lab specializes in the development of advanced drug delivery systems, with a focus on enhancing the bioavailability, targeting, and therapeutic efficacy of bioactive compounds. The lab investigates nanomaterials and novel formulations—such as proliposomes, PEGylated polymers, and clay-based composites—for targeted delivery of drugs and natural compounds, including ginsenosides, celecoxib, and orobol. Their work emphasizes physicochemical engineering of nanoparticles to optimize biodistribution, stability, and in vivo performance, particularly for oral and topical applications. The lab also explores photodynamic therapy agents to improve tumor targeting and treatment outcomes in oncology.
Research Overview
Research Output Trend
Figures are computed from collected data and may differ slightly.
Selected Papers
15Nanoparticles (NPs) have been extensively researched for targeted diagnostic imaging and drug delivery, yet their clinical translation remains limited, with only a few achieving Food and Drug Administration approval. This limited success is primarily due to challenges in achieving precise organ- or tissue-specific targeting, which arise from off-target tissue accumulation and suboptimal clearance profiles. Herein we examine the critical role of physicochemical properties, including size, surface
The developed PLs formulation could be a favorable delivery system to improve the oral bioavailability of ginsenosides, including Rg3.
PEGylated Eudragit L100 (ELP)-containing proliponiosomes (PLNs) were developed for improved oral delivery of celecoxib (CXB). The successful introduction of PEG 2000 or 5000 to Eudragit L100 (EL) was confirmed via proton nuclear magnetic resonance analysis of which calculated molar substitution ratio of PEG to EL was 36.0 or 36.7, respectively. CXB, ELP, phospholipid, and non-ionic surfactants were dissolved in dimethyl sulfoxide and lyophilized to produce CXB-loaded PLNs (CXB@PLNs). The physica
Purpose: Orobol is an isoflavone that has a potent skin protection effect. The objective of this study was to prepare a novel bentonite-based composite formulation of orobol to enhance topical skin delivery. Methods: The composition was optimized based on the orobol content in the composite and the in vitro release studies, followed by the in vitro and in vivo hairless mouse skin deposition studies. Physicochemical characterizations of the composite formulation were performed by powder X-ray ref